Ronald Silver

CIK: 0001873731

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRWD

IRONWOOD PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

IRWD
IRONWOOD PHARMACEUTICALS INC
Jul 7, 2026
Sale(S)
Direct
127.9K shares at avg. $4.52$578K
IRWD
IRONWOOD PHARMACEUTICALS INC
May 19, 2026
Award(A)
Direct
25K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Mar 10, 2026
Award(A)
Direct
163.9K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 24, 2026
Sale(S)
Direct
12.6K shares at avg. $3.66$46K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 23, 2026
Sale(S)
Direct
11.6K shares at avg. $3.81$44K
IRWD
IRONWOOD PHARMACEUTICALS INC
Jan 5, 2026
Sale(S)
Direct
35.4K shares at avg. $4.60$163K
IRWD
IRONWOOD PHARMACEUTICALS INC
Aug 11, 2025
Sale(S)
Direct
2.8K shares at avg. $0.84$2K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 10, 2025
Sale(S)
Direct
12K shares at avg. $1.76$21K
IRWD
IRONWOOD PHARMACEUTICALS INC
Jan 27, 2025
Award(A)
Direct
133.3K shares-

		Type	Shares	Price		Ownership
Jul 7, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	127,890	$4.52	$578,063	Direct
May 19, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	25,000	-	$0	Direct
Mar 10, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	163,934	-	$0	Direct
Feb 24, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	12,621	$3.66	$46,193	Direct
Feb 23, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	11,552	$3.81	$44,013	Direct
Jan 5, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	35,416	$4.60	$162,914	Direct
Aug 11, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	2,846	$0.84	$2,391	Direct
Feb 10, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	12,048	$1.76	$21,204	Direct
Jan 27, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	133,333	-	$0	Direct

1-9 of 9 transactions

About Silver Ronald

Silver Ronald (SEC CIK 0001873731) files insider reports with the SEC as PFO & PAO of IRONWOOD PHARMACEUTICALS INC (IRWD).

Signal8 holds 8 ownership filings by Silver Ronald, all Form 4s, filed between Jan 29, 2025 and Jul 9, 2026. Those filings report 9 transactions, from Jan 27, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Silver Ronald's filings is in BOSTON, MA.

Recent filings by Silver Ronald

Jul 7, 2026: Open-market sale of IRWD shares (Form 4, code S).
May 19, 2026: Grant or award of IRWD shares (Form 4, code A).
Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).

Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)

DENNER ALEXANDER J, Director
Silber Jeffrey, SVP, CMO, Head-Res&Drug
Shepard Jay, Director
Kessler Marla L, Director
Currie Mark G, Director
Duane Jon R, Director

How to read Form 4 transaction codes